LeMaitre Vascular

LMAT Mid Cap

Healthcare · Medical Instruments & Supplies

Updated: Apr 5, 2026, 17:43 UTC

$108.49

-0.24% today

52W: $71.42 – $115.33

52W Low: $71.42 Position: 84.4% 52W High: $115.33

🔗 Compare Brokers

Key Metrics

P/E Ratio

43.05x

Price-to-Earnings

Forward P/E

34.07x

Forward Price/Earnings

P/S Ratio

9.9x

Price-to-Sales

EV/EBITDA

31.25x

Enterprise Value/EBITDA

Div. Yield

92%

Annual dividend yield

Market Cap

$2.5B

Market Capitalization

Revenue Growth

15.7%

YoY Revenue Growth

Profit Margin

23.13%

Net profit margin

ROE

15.8%

Return on Equity

Beta

0.67

Market sensitivity

Short Interest

7.46%

% of float sold short

Avg. Volume

216,288

Average daily volume

Valuation Analysis

Signal

Overvalued

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

9 analysts

Avg. Price Target

$111.22

+2.52% upside

Target Range

$94.00 – $124.00

About the Company

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; X

Sector: Healthcare Industry: Medical Instruments & Supplies Country: United States Employees: 646 Exchange: NGM